Webinar: MRD Detection, Regardless of Tissue Availability

Tuesday, May 18, 2021 at 1:00 p.m. ET

One of the biggest challenges for conventional MRD assays has been obtaining the archived baseline tissue sample. PredicineALERT™, a liquid-based approach to MRD detection, overcomes this challenge by providing personalized and baseline-informed molecular insights for ongoing treatment response and recurrence of cancer without the need for a baseline tissue sample.

During this webinar we will highlight the approaches we are developing at Predicine that allow for the flexibility of using liquid or tissue to inform and personalize a highly sensitive minimal residual disease assay for longitudinal monitoring of cancer recurrence.

Date: Tuesday, May 18, 2021
Time: 1:00 PM EDT / 10 AM PDT

Topics to be covered:

  • Tissue-agnostic MRD Detection
  • Personalized and baseline-informed approach
  • Plasma and urine ctDNA analysis for MRD assessment

Register Now

Overview

Title: MRD Detection, Regardless of Tissue Availability

Date: Tuesday, May 18, 2021

Time: 1:00pm Eastern Standard Time

Duration: 40 minutes